JNJ Johnson & Johnson

Price (delayed)

$164.05

Market cap

$431.86B

P/E Ratio

24.34

Dividend/share

$4.14

EPS

$6.74

Enterprise value

$451.01B

Johnson & Johnson is an American multinational corporation founded in 1886 that develops medical devices, pharmaceutical, and consumer packaged goods. Its common stock is a component of the Dow Jones ...

Highlights
JNJ's price to earnings (P/E) is 65% lower than its 5-year quarterly average of 70.1 and 6% lower than its last 4 quarters average of 26.0
Johnson & Johnson's net income has increased by 18% QoQ and by 17% YoY
Johnson & Johnson's debt has increased by 10% YoY

Key stats

What are the main financial stats of JNJ
Market
Shares outstanding
2.63B
Market cap
$431.86B
Enterprise value
$451.01B
Valuations
Price to earnings (P/E)
24.34
Price to book (P/B)
6.21
Price to sales (P/S)
4.84
EV/EBIT
22.14
EV/EBITDA
16.19
EV/Sales
5.06
Earnings
Revenue
$89.19B
EBIT
$20.37B
EBITDA
$27.86B
Free cash flow
$22.56B
Per share
EPS
$6.74
Free cash flow per share
$8.57
Book value per share
$26.42
Revenue per share
$33.88
TBVPS
$34.33
Balance sheet
Total assets
$176.44B
Total liabilities
$106.86B
Debt
$33.48B
Equity
$69.58B
Working capital
$15.05B
Liquidity
Debt to equity
0.48
Current ratio
1.39
Quick ratio
1.04
Net debt/EBITDA
0.69
Margins
EBITDA margin
31.2%
Gross margin
67%
Net margin
19.9%
Operating margin
25.2%
Efficiency
Return on assets
10.2%
Return on equity
27%
Return on invested capital
30.2%
Return on capital employed
14.8%
Return on sales
22.8%
Dividend
Dividend yield
2.52%
DPS
$4.14
Payout ratio
61.4%

JNJ stock price

How has the Johnson & Johnson stock price performed over time
Intraday
-0.71%
1 week
-1.75%
1 month
-8.59%
1 year
11.47%
YTD
4.24%
QTD
-0.42%

Financial performance

How have Johnson & Johnson's revenue and profit performed over time
Revenue
$89.19B
Gross profit
$59.75B
Operating income
$22.51B
Net income
$17.77B
Gross margin
67%
Net margin
19.9%
Johnson & Johnson's net income has increased by 18% QoQ and by 17% YoY
The gross profit is up by 13% YoY and by 7% QoQ
The operating income rose by 13% year-on-year and by 11% since the previous quarter
JNJ's revenue is up by 11% year-on-year and by 6% since the previous quarter

Growth

What is Johnson & Johnson's growth rate over time

Valuation

What is Johnson & Johnson stock price valuation
P/E
24.34
P/B
6.21
P/S
4.84
EV/EBIT
22.14
EV/EBITDA
16.19
EV/Sales
5.06
JNJ's price to earnings (P/E) is 65% lower than its 5-year quarterly average of 70.1 and 6% lower than its last 4 quarters average of 26.0
The EPS has grown by 17% from the previous quarter and by 17% YoY
JNJ's price to book (P/B) is 12% more than its 5-year quarterly average of 5.6 but 2.3% less than its last 4 quarters average of 6.4
JNJ's equity is up by 10% year-on-year and by 6% since the previous quarter
JNJ's revenue is up by 11% year-on-year and by 6% since the previous quarter
The price to sales (P/S) is 6% more than the 5-year quarterly average of 4.6 but 2.4% less than the last 4 quarters average of 5.0

Efficiency

How efficient is Johnson & Johnson business performance
The return on assets has increased by 15% since the previous quarter and by 5% year-on-year
The company's return on equity rose by 14% QoQ and by 8% YoY
The ROS has grown by 11% YoY and by 9% from the previous quarter
Johnson & Johnson's return on invested capital has increased by 11% QoQ

Dividends

What is JNJ's dividend history
DPS
$4.14
Dividend yield
2.52%
Payout ratio
61.4%
Recent dividends

Financial health

How did Johnson & Johnson financials performed over time
JNJ's total assets is 65% greater than its total liabilities
The quick ratio has increased by 13% YoY and by 7% QoQ
Johnson & Johnson's total liabilities has increased by 12% YoY
Johnson & Johnson's debt is 52% less than its equity
Johnson & Johnson's debt has increased by 10% YoY
JNJ's equity is up by 10% year-on-year and by 6% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.